The fourth Subject was safely treated with the low-dose of BB-301 in December 2024, and the fifth Subject was safely treated with the low-dose of BB-301 in early February 2025. The sixth Subject is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback